Interpace Biosciences®, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Preferred Stock and Equity Offerings (Details Narrative)

Preferred Stock and Equity Offerings (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands											3 Months Ended	12 Months Ended
	Oct. 12, 2017	Jul. 07, 2017	Jul. 05, 2017	Jun. 21, 2017	Jun. 16, 2017	Apr. 18, 2017	Mar. 22, 2017	Feb. 08, 2017	Jan. 25, 2017	Jan. 06, 2017	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Jul. 31, 2017
Preferred stock, shares authorized												5,000,000	5,000,000
Net proceeds from equity offerings													$ 29,900
Number of common stock issued, shares				9,900,000
Proceeds from issuance of common stock													23,081
Warrants to purchase shares of common stock														875,000
Fair value of warrants issued											$ 200	112	141
Option to purchase overallotment option, percentage					4.00%
Warrant term			3 years
Debt conversion, converted instrument, amount													$ 11,643
Loss on conversion of convertible debt												4,300
Underwriters' overallotment option to purchase common stock					1,875,000
Warrant exercised													1,700,000
Warrant exercise price	$ 1.80		$ 1.25	$ 1.25			$ 4.69		$ 4.69
Underwriters purchase common stock, value														$ 960
Warrant expiring date			Aug. 31, 2020
Warrants exercisable into common stock			150,000
Other (expense) income, net												$ 263	$ (2,128)
Gross proceeds from warrant exercise													$ 2,100
Number of common stock in connection with contracts for consulting services												800,000
Underwriter Discount [Member]
Underwriters purchase common stock, value														$ 72
RedPath Note [Member] \| Senior Secured Non-Convertible Note [Member]
Debt conversion, converted instrument, amount						$ 3,550
Debt conversion, converted instrument, shares issued						3,795,429
Termination Agreement [Member] \| RedPath Equityholder Representative [Member]
Warrants to purchase shares of common stock							100,000
Common stock purchase price per share							$ 4.69
Fair value of warrants issued							$ 190
Warrant term							5 years
First Registered Direct Offering [Member]
Number of common stock issued, shares										630,000
Common stock price, per share										$ 6.81
Proceeds from issuance of common stock										$ 4,300
Second Registered Direct Offering [Member]
Number of common stock issued, shares									855,000
Fair value of warrants issued									$ 1,670
Second Registered Direct Offering [Member] \| Private Placement [Member]
Warrants to purchase shares of common stock									855,000
Common stock purchase price per share									$ 4.69
Proceeds from issuance or sale of equity									$ 4,000
Confidentially Marketed Public Offering (CMPO) [Member]
Number of common stock issued, shares								1,200,000
Common stock price, per share								$ 3.00
Proceeds from issuance or sale of equity								$ 3,900
Option to purchase overallotment option, percentage								9.00%
Common Stock [Member]
Number of common stock issued, shares												867,000	34
Warrants to purchase shares of common stock					9,900,000
Base Warrants [Member]
Number of common stock issued, shares				12,500,000
Warrants to purchase shares of common stock					12,500,000
Common stock purchase price per share					$ 1.25
Fair value of warrants issued				$ 5,300
Common stock effective purchase price					$ 1.10
Underwriters' overallotment option to purchase common stock					1,875,000
Underwriter Warrants[Member]
Number of common stock issued, shares				575,000
Warrants to purchase shares of common stock					2,600,000
Common stock purchase price per share					$ 0.01
Warrant exercise price												$ 1.32
Base Warrant And Prefunded Warrants [Member]
Common stock effective purchase price					$ 1.09
Pre-Funded Warrants [Member]
Number of common stock issued, shares				2,600,000
Warrants to purchase shares of common stock		2,600,000
Fair value of warrants issued		$ 2,300
Underwriting discount rate					7.50%
Offering and over-allotment and reasonable out-of-pocket expenses					$ 100
Warrant exercised		2,600,000
Warrant exercise price		$ 0.01										$ 0.01
Proceeds from warrants		$ 26,000
Overallotment Warrants [Member]
Number of common stock issued, shares				1,875,000
Fair value of warrants issued				$ 800
4 Million Base Warrants [Member]
Common stock purchase price per share	$ 1.25
Proceeds from warrants	$ 5,000
Other (expense) income, net	$ 2,000
4 Million Base Warrants [Member] \| Private Placement [Member]
Warrants to purchase shares of common stock	3,200,000
Warrant exercise price	$ 1.80